Related Experiment Videos
Molecular correlates in the progression of normal melanocytes to melanomas
1Department of Dermatology, Yale University School of Medicine, New Haven, CT 06510.
Abstract:
The malignant phenotype of melanocytes in vitro is characterized by growth factor autonomy, refractory to inhibitors and loss of differentiated functions. The molecular basis for these changes is not yet fully understood but it is likely to involve the inappropriate expression of specific genes that confer growth advantage due to loss and/or inactivation of tumor suppressing genes. The aberrant expression of basic fibroblast growth factor (bFGF) is one of the early and common events in melanocytic lesions, eliciting an intracellular loop of autocrine growth, dedifferentiation, but not tumorigenicity. Dysregulation of bFGF is due to gene activation probably as a result of a loss and/or inactivation of a tumor suppressor gene. A putative melanoma suppressor gene deleted in dysplastic nevi and melanomas has been recently mapped to chromosomal position 9p21. Loss of others, on chromosomes 1 and 6, has been implicated in later stages of malignant progression. Thus, further understanding the molecular basis of growth controls in melanocytes and the causes of malignant transformation is dependent on the identification of the melanoma suppressor genes and elucidation of their function.
Insights
Melanoma development involves genetic changes leading to uncontrolled melanocyte growth. Identifying melanoma suppressor genes is crucial for understanding malignant transformation and developing targeted therapies.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Malignant melanocytes exhibit uncontrolled growth, resistance to inhibitors, and loss of differentiation.
- The molecular mechanisms underlying melanoma development are not fully understood, but likely involve gene dysregulation and tumor suppressor gene inactivation.
Purpose of the Study:
- To investigate the molecular basis of growth control in melanocytes.
- To understand the causes of malignant transformation in melanoma.
- To identify key melanoma suppressor genes and elucidate their functions.
Main Methods:
- Analysis of gene expression patterns in malignant melanocytes.
- Mapping of putative melanoma suppressor genes to specific chromosomal locations.
- Investigation of the role of basic fibroblast growth factor (bFGF) in melanocyte transformation.
Main Results:
- Aberrant expression of basic fibroblast growth factor (bFGF) is an early event in melanocytic lesions, promoting autocrine growth and dedifferentiation.
- A putative melanoma suppressor gene has been mapped to chromosome 9p21, with losses implicated in dysplastic nevi and melanomas.
- Loss of other tumor suppressor genes on chromosomes 1 and 6 is associated with later stages of melanoma progression.
Conclusions:
- Understanding melanoma requires identifying and characterizing melanoma suppressor genes.
- Dysregulation of bFGF signaling, linked to tumor suppressor gene inactivation, plays a role in early melanocytic lesion development.
- Further research into melanoma suppressor genes is essential for elucidating malignant transformation pathways.